The gene coding the transcription factor HNF-4α is located on chromosome 20q and is expressed in the liver, pancreas, kidneys, stomach and in the small and large intestine, where it controls important aspects related to morphogenesis and epithelial function. Mucin type MUC4 and MUC2, and β-catenin are representative genes controlled by HNF-4α and expressed in colonic tissue. We used in the present study immunohistochemical analyses to detect different levels of expression of the above mentioned proteins in colonic tissues of colorectal cancer and ulcerative colitis patients. We demonstrate high expression levels of HNF-4α in normal colon tissue, however, in adenoma, HNF-4α levels of expression decreased and in carcinoma of the large intestine; the levels were very low or invisible. Similarly, in ulcerative colitis patients the expression HNF-4α levels of the protein were significantly lower than the control group. Expression levels of MUC2 and MUC4 levels were significantly lower in the adenocarcinoma and ulcerative colitis groups than in the control group. In contrast, the expression level of β-catenin increased and changed from a membrane to a nuclear localization in the adenocarcinoma group only. We surmise that HNF-4α plays an important role in prevention of ulcerative colitis and colorectal cancer in humans. As a result, altered expression of the proteins MUC2 and MUC4 controlled by HNF-4α indicate that the defensive role attributed to them is not properly performed. In contrast, the Wnt / β-catenin pathway controlled by HNF-4α becomes active in samples from the stage of the adenoma and reached its peak in the carcinoma samples.
Introduction
HNF-4α is the first nuclear receptor identified from the HNF-4 family and was later associated with the NR2A1 liganddependent transcription factor family (1). The gene for HNF-4α is located on chromosome 20, q13.1-13.2. The gene contains at least 12 axons and contains 2 promoters: P1 promoter (P1-HNF-4α) and P2 promoter (P2-HNF-4α). HNF-4α binds to DNA as a homodimer only, to regions of AGGTCA X AGGTCA in the target genes (2). HNF-4α is normally expressed in liver tissue, in proximal kidneys, in β cells in the pancreas and epithelial cells of the small and large intestine. In liver hepatocytes, HNF-4α is expressed at the highest level (2). Silencing the gene for HNF-4α in the mouse caused fetal death during the gastrulation phase (6.5E) due to a defect in the formation of the vesicular endoderm (3). HNF-4α is expressed in the nucleus of epithelial epithelial cells of the mucosa layer of the small and large intestine (4). It is expressed at a high level in the intestinal epithelium from duodenum to the colon, from crypt to villus (3, 5). HNF-4α controls genes that give the intestine its unique physiologic characteristics. Among the genes controlled by HNF-4α in the colonic tissue are Mucin 2 (MUC2), Mucin 4 (MUC4), and β-catenin (3, 5). In a study assessing the role of HNF-4α in the intestine in mouse embryos, it was found that HNF-4α is essential for normal bowel development (5). Inactivation of the HNF-4α gene in the fetal colon epithelium, although allowing early stages of bowel development, caused an abnormality in the formation of crypts. Both, a small number of differentiated tubular cells and lower proliferation of epithelial cells accompanied this phenomenon. HNF-4α was also demonstrated to control the final differentiation of colon epithelial cells by controlling expression of additional genes (5). Inactivation of HNF-4α in adult mouse tissue affects the line of intestinal cells and leads to an increase in the number of abnormal and atrophic cells. An additional effect was found in the level of cell stability and their location in the cell (3). The transcription activity itself is closely controlled also by epigenetic mechanisms (6). The association between HNF-4α and the Wnt / β-catenin pathway was demonstrated by Cattin et al (3). A greater amount of intracellular β-catenin was seen in crypts of mice lacking HNF-4α in intestinal cells compared with the control group, whereas cytoplasmic β-catenin did not change, the amount of nuclear β-catenin increased by 50% in mice not expressing HNF-4α. β-catenin is a multi-role protein, both in the intracellular interface and in the Wnt pathway, which is involved, inter alia, in the process of regeneration of epithelial cells in the intestine. This protein can also be expressed in the cell membrane, both in the cytoplasm and in the nucleus, depending on its control. When analyzing other components of the Wnt / β-catenin, such as Tcf-4, Axin 2, and c-Myc were significantly higher in mice that did not express HNF-4α than control mice. It was also found that HNF-4α in the colonic epithelium control cell proliferation by interacting with the Tcf-4 transcription factor and thereby interfering with the Wnt / β-catenin pathway (3). The mucosal layer of the large intestine contains the cellular units called crypts (7), these crypts contain eight cell types that make up the intestinal epithelium, and each has structural characteristics that allow its Medical Research Archives. Volume 5, issue 9. September 2017. Mucins are large glycosylated glycoproteins with a protein-rich backbone structure and are associated with a wide range of oligosaccharides, which account for more than 70% of the weight of the molecule (13). MUC2 is synthesized and secreted from the goblet cells in the colon and is a specific phenotypic marker for the differentiation of these cells (14). MUC2 is the main source of the excretory secrete group synthesized and secreted from goblet cells in the colon and is a phenotypic specific marker for cell differentiation (15). The gene coding for MUC2 is located on chromosome 11 (12). The MUC2 monomer has more than 5,000 amino acids that contain regions of tandem repeats rich in proline, serine, and threonine. The MUC2 monomer after the glycosylation process has a mass of 2.5 MDa and the polymer can reach above 100 MDa. MUC4 is a mucin expressed in epithelial cells of the respiratory system, gastrointestinal tract, and genital system in both stages of embryonic development and in adults (13) before and after cell differentiation and is mainly attributed to the intestine. One, as membrane-bound protein prior to differentiation, and the other as membranebound protein and excreted protein after cell differentiation (16). The gene for MUC4 is located on chromosome 3 (17). The gene contains two promoters, one close and the other distant. The expression of MUC4 is partly controlled by interferon-ɣ retinoic acid and transforming factor-β (17). Analysis of the gene sequence showed that there are many binding sites to HNF-4α located in the distant promoter of MUC4. Our previous study (6); demonstrate that MUC4 is a target for HF-4α. Inhibition of HNF-4α transcription at the epigenetic level exerted a reduction in MUC4 gene transcription and other genes associated with proliferation such as PCNA. In patients with colorectal cancer, there are different expression levels of MUC4 ranging from lack of expression to high expression. Shanmugam et al (18) demonstrated that when MUC4 is highly expressed in colorectal tumors a poorer prognosis was evident. Several studies have shown that nuclear receptors have a critical relationship to the pathogenesis of inflammatory bowel disease, including: Vitamin D receptor (19) . In recent years, genetic studies have linked inflammatory bowel disease with several factors involved in epithelial regeneration, such as HNF-4α (20) . Genome-wide association and genotyping in patients with colitis compared to controls showed significant association with the site on the Medical Research Archives. Volume 5, issue 9. September 2017. 
Immunohistochemical analyses:
Four-micron slices of tissues fixed in formalin 4% and embedded in paraffin were sectioned in a microtome (Reichert-Jung 2030) and placed onto positive extraadhesive slides. The sections underwent a process of deparafinization in xylene and in absolute ethanol. Antigen retrieval was performed using pressure cooker treatment for 20 minutes in citrate buffer pH 6. To block endogenous peroxidase, sections were incubated for 15 minutes in 3% H 2 O 2 methanol solution and then washed with doubled distilled water (DDW). The sections were blocked for 20 min with 5% (v/v) horse serum and 1% (v/v) goat serum to prevent unspecific binding of the antibody.
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The sections were then incubated for one hour at room temperature with the following primary antibodies: rabbit polyclonal anti β-Catenin (ap15398pu-M) (Acris, Germany) used at 1:150 dilution; mouse monoclonal anti MUC2 (AM11177PU-M); (Acris, Germany) used at 1:200 dilution; rabbit polyclonal anti MUC4 (NBP1-86505); (NOVUS Biologicals, UK) used at 1:100 dilution. For nuclear antigens a nuclear decloaker pH 9 (Biocare Medical Pacheco, CA, USA) was used. The nuclear antibodies mouse monoclonal anti HNF-4α (ab 41898) (Abcam, Cambridge UK) used at 1:200 dilution and rabbit monoclonal anti Ki67 (rm-9106-s) (Thermo scientific, Paisley, UK) used at 1:100 dilution. After the antigen retrieval process, the sections were cooled for 20 minutes at room temperature, washed with distilled water, sealed and transferred to a semi-automatic immunohistochemical device (Biogenex i6000, CA, USA). Sections were washed three times in PBS and then incubated with corresponding HRP-conjugated anti-rabbit antibody (Jackson ImmunoResearch Laboratories, Inc, West Grove, PA, USA). Immunodetection was performed with DAB substrate buffer (Zytomed systems, Anhaltinerstr, Berlin, Germany). For visualization of nuclei, the sections were counterstained with Mayer's haematoxylin (Pioneer research chemicals limited, Essex, UK).
At the end of the immunohistochemical procedure to HNF-4α staining some sections were counterstained with Periodic Acid Schiff (PAS) (Zytomed Systems, Anhaltinerstr, Berlin, Germany).
PAS is used to distinguish tissues and cells reach in carbohydrates, such as mucin, glycogen, and basal membrane. The sections were washed with distilled water and then exposed Periodic Acid for 10 minutes. Finally, the sections were washed in tap water. The sections were finally covered with an automatic covering device (Sakura, Tissue Tek-film, Japan). 
Statistical methods
A preliminary Kolmogorov Seminarov test was conducted to examine the distribution of the main dimensions of the study, in order to ensure that the indices are normal and determine whether a parametric or aparametric test is needed. The test resulted that an a-parametric test is needed, and therefore we used the Kruskal Valis test for comparison between more than two independent samples . The significance level for the various tests was at p <0.05.
Results
Representative images of the normal mucosa group, the adenoma group and the carcinoma group that underwent immunohistochemical and histochemical analyses for the following proteins: MUC2, MUC4, HNF-4α, PAS, Ki67 and β-catenin. Significant differences in the expression of proteins in controls versus adenoma and carcinoma cases are evident.
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Copyright 2017 KEI Journals. All Rights Reserved. β-catenin staining is shown in Fig. 1 A-C. In normal mucosa (A) β-catenin staining appears to be expressed either at membrane or at cytoplasmic domains. In adenoma (B) a cytoplasmic and even slightly a nuclear domain β-catenin staining is evident. In carcinoma (C), the intensity of the staining is strong and is located in a large number of cell nuclei, indicating that Wnt / β-catenin pathway is activated. Fig. 1 D-F shows MUC2 staining. In normal mucosa (D), MUC2 expression is strong, in adenoma (E), the mucin expression is still strong however in carcinoma (F), a relatively small amount of cells are stained. MUC4 staining is shown in Fig. 1 
Control Chronic Ulcerative Acute Ulcerative Colitis Colitis
Medical Research Archives. Volume 5, issue 9. September 2017. Fig. 2 A-C shows β-catenin staining. In normal mucosa (A) β-catenin staining is low and appears to be associated with membrane and cytoplasm. In chronic (B) and acute ulcerative colitis (C), most of the cases were characterized by membrane and / or cytoplasmic staining that characterizes normal expression of β-catenin. . Differences in ISS scoring in the expression of β-catenin nuclear (nuclear) and β-catenin nuclear (membrane) tested between the control group, the adenoma group, and the carcinoma group. Substantial differences were obtained in the expression of β-catenin nuclear (nuclear). No difference was obtained for β-catenin membrane. * p <0.001; ** p <0.017.
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Nuclear β-catenin protein expression of adenoma was found to have a significant difference from the control group (* p <0.017). Nuclear β-catenin protein expression of the carcinoma group differed also significantly from the control (** p <0.001) and from the adenoma (** p <0.001). It can be noticed that nuclear β-catenin levels starts to increase in the adenoma tissue and reach its peak in tumor tissue. In contrast, no significant difference was found between membrane β-catenin expression (p = 0.02). 
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Figure 5. Significant differences in ISS representing MUC4 expression was found between the adenoma and carcinoma groups and between the adenoma and control groups (** p < 0.017) and between the control and carcinoma groups (* p < 0.01).
Figure 5 shows significant differences in the expression of MUC4 between the three groups. The significant difference of MUC4 expression between the carcinoma group and the control group and between the carcinoma group and the adenoma group indicate that during the progress of malignancy, MUC4 expression is consistently downregulated. Figure 6 . Comparison of PAS staining and HNF-4α expression between control group, adenoma group and colon carcinoma group. Significant differences in ISS representing HNF-4α expression was found between the adenoma and carcinoma groups and between the adenoma and control groups (** p < 0.017) and between the control and carcinoma groups (* p < 0.01). For PAS staining significant differences in ISS was found between the adenoma and carcinoma groups and between the control and carcinoma groups (* p < 0.01) and between the adenoma and control groups (** p < 0.017).
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There is a significant difference in PAS staining between the study groups. This difference is indicative for variation in cells able to synthesize mucins. It means that the number of goblet and columnar crypt cells populating the colonic epithelium decreases steeply from adenoma to carcinoma and both are lower than the control group. When HNF-4α protein was tested, significant differences were also found between the groups. We can summarize that the expression of the HNF-4α protein decreased as the process of progression towards malignancy take place and in carcinoma the level of HNF-4α was the lowest.
We proceed with scoring analyses in control versus chronic ulcerative colitis and acute ulcerative colitis groups. Since no significant differences were measured between the ulcerative colitis groups (chronic and acute) for the process of scoring we unified this two groups. As a whole, significant differences are discernable in the expression of PAS staining, MUC2, MUC4, and HNF-4α expression between control group, and ulcerative colitis group. However, no significant differences were observed for the expression of membrane and nuclear β-catenin expression (see Fig. 7 ). Comparison of ISS for PAS staining, MUC2, MUC4, membrane and nuclear β-catenin expression and HNF-4α expression between control group, and ulcerative colitis group. Significant differences in ISS representing PAS staining, MUC2 and MUC4 expression and HNF-4α expression was found between the ulcerative colitis patients and control groups (* p < 0.01). No significant differences were found for membrane and nuclear β-catenin expression.
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ulcerative colitis and colorectal cancer tissues DISCUSSION HNF4-α is a transcription factor belonging to a large family of ligand-dependent nuclear receptors (1). HNF-4α is unique in that it binds to DNA as a homodimer, to regions in the promoter containing sequences (AGGTCA X AGGTCA). HNF-4α active binding sites have been identified in more than 140 genes, including those involved in glucose, lipid, amino acid and drug metabolism, but in the past few years, about 240 direct HNF-4α sites have been identified for other activities such as signal transmission, immune response, DNA repair, cell structure, programmed cell death and others (23) . Nine different isoforms of HNF-4α have been identified and being these isoforms the result of the activity of two promoters P1 and P2. The expression of these promoters varies in different tissues; only the small and large intestine tissues express these two types of promoters (24) . It is known that HNF-4α play an important role in the development and normal functioning of the intestine, at the level of epithelial morphology and differentiation (25) , cell junction assembly and adhesion (26) and cell proliferation (27) . There are also evidences for the association between HNF-4α and colorectal cancer (24, 27) . The aim of our study was to examine the extent of expression of HNF-4α and proteins controlled by HNF-4α in the intestinal tissue of colorectal cancer and ulcerative colitis patients in order to understand their putative role in the development of colorectal cancer and ulcerative colitis in humans. A previous study conducted in our laboratory demonstrated that HNF-4α is highly expressed in malignant colon cells. Silencing HNF-4α gene expression in HT29 malignant cells by siHNF-4α inhibited the proliferation of these malignant cells. (27 (35) demonstrated that silencing the HNF-4α gene in the intestinal cells followed by the exposure of mice to dextran sodium sulfate (DSS) induced worsened changes in the clinical and pathological symptoms associated with inflammatory bowel disease such as enhanced weight loss, reduced colon length, and altered histological morphology. Their conclusion was that HNF-4α protects against ulcerative colitis caused by exposure to DSS (35) . Regarding β-catenin expression we found that nor the extent level nor the distribution of β-catenin expression in the mucosa cells in ulcerative colitis patients was significantly different from the expression in the normal tissue. Regarding the expression levels of MUC2 and MUC4 in patients with ulcerative colitis, the levels of these two mucin molecules were lower in all ulcerative colitis patients than in control. The mucosal expression level of MUC2 decreases significantly in the ulcerative colitis group compared to the control group, which is supported by the fact that PAS staining is significantly lower, i.e., the number of mature goblet cells decreases significantly. In this regards, it was previously demonstrated that production and excretion of MUC2 decreases primarily in the active stage of the disease (36) , so that the epithelial barrier loses its protective function. In addition, it was found that in the active stage of ulcerative colitis, MUC2 rarely undergoes a sulfate binding process and only MUC2 undergoing this process is electively excreted. This type of MUC2 is less resistant to bacterial stress and less resistant to enzymatic degradation (36 These findings show that the mucin MUC2 can build a mucus barrier that separates bacteria from the colon epithelia and suggest that defects in this mucus can cause colon inflammation. A similar trend was also observed for expression of MUC4 in the ulcerative colitis group. A significant reduction was seen in the ulcerative colitis group compared with the control group, so it is clear that the protective layer of the intestinal mucosa is severely impaired. As previously mentioned, PAS staining was also decreased in ulcerative colitis group compared with the control group. Similarly, Dorofeyev et al. (39) demonstrated that the number of goblet cells decreased as the disease worsened. In summary, our study demonstrates that the expression level of HNF-4α protein and the proteins under its control in various pathological conditions that impair the functioning of the human colon are also in disarray. HNF-4α appears to play a major role, since in the early stages of these diseases the protein expression was damaged.
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